Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease

Informazioni relative al progetto

GENEGUT

ID dell’accordo di sovvenzione: 101057491

DOI

10.3030/101057491

Data della firma CE 19 Maggio 2022

Data di avvio 1 Ottobre 2022

Data di completamento 30 Settembre 2026

Finanziato da

• Health

Costo totale

€ 4 601 216,25

Contributo UE

€ 4 601 215,00

Coordinato da

UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
Ireland

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Data Management Plan (1)

Data Management Plan (DMP)

Data Management Plan (DMP) (Task 7.4, UCC, M6, 48) In this document, the consortium will lay down its plan for research data management throughout the duration of the project and will deliver an update within each periodic report as well as a final version in M48.

Documents, reports (3)

Development of predictive in vitro methods for development of targeted DDS in CD patients

Development of predictive in vitro methods for development of targeted DDS in CD patients using simulated patient and animal intestinal fluids (Tasks 3.3, Lonza, M36).

Interim impact report II

Interim impact reports to provide an overview of the communication and dissemination activities achieved to date and assess their impact by means of Key Impact Pathways. (Task 6.1-2, accelCH, M18, 36).

Interim impact report I

Interim impact reports to provide an overview of the communication and dissemination activities achieved to date and assess their impact by means of Key Impact Pathways. (Task 6.1-2, accelCH, M18, 36).

Websites, patent fillings, videos etc. (2)

GENEGUT training materials I

GENEGUT training materials incl. specific workshops, best practices, modules (Task 6.1, EFCCA,M24,48).

GENEGUT website

GENEGUT website with dedicated areas for different stakeholder groups (Task 6.1, accelCH, M2).

Pubblicazioni

Peer reviewed articles (5)

European Journal of Pharmaceutical Sciences

Autori: Elisa Millet., Joseph P O’Shea, Brendan T Griffin, Camille Dumont, Vincent Jannin
Pubblicato in: European Journal of Pharmaceutical Sciences, 2025, ISSN 0928-0987
Editore: Elsevier B.V.
DOI: 10.1016/J.EJPS.2025.107277

Tailoring Alkyl Side Chains of Ionizable Amino-Polyesters for Enhanced In Vivo mRNA Delivery

Autori: Aida López Espinar, Lianne M. Mulder, Mohamed Elkhashab, Zahra Khan, Mariusz Czarnocki-Cieciura, Maria R. Aburto, Sonja Vucen, Piotr S. Kowalski
Pubblicato in: ACS Applied Bio Materials, Numero 8, 2025, ISSN 2576-6422
Editore: American Chemical Society (ACS)
DOI: 10.1021/ACSABM.5C00116

Journal of Controlled Release

Autori: Bárbara Ferreira, Cecília Ferreira, Cláudia Martins, Rute Nunes, José das Neves, Catarina Leite-Pereira, Bruno Sarmento
Pubblicato in: Journal of Controlled Release, 2024, ISSN 0168-3659
Editore: Elsevier BV
DOI: 10.1016/J.JCONREL.2024.11.070

Trends in 3D models of inflammatory bowel disease

Autori: Bárbara Ferreira, Andreia S. Barros, Catarina Leite-Pereira, Juliana Viegas, José das Neves, Rute Nunes, Bruno Sarmento
Pubblicato in: Biochimica et Biophysica Acta (BBA), Numero Volume 1870, Numero 3, 2024, ISSN 0925-4439
Editore: Elsevier
DOI: 10.1016/J.BBADIS.2024.167042

State-of-the-Art and Future Perspectives in Ingestible Remotely Controlled Smart Capsules for Drug Delivery: A GENEGUT Review

Autori: Sophia V. Hoffmann, Joseph P. O'Shea, Paul Galvin, Vincent Jannin, Brendan T. Griffin
Pubblicato in: European Journal of Pharmaceutical Sciences, 2024, ISSN 0928-0987
Editore: Elsevier B.V.
DOI: 10.1016/J.EJPS.2024.106911